DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce

7680679590014 CH-67959 G04CA52
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Articles (1)

Dutasterid Tamsulosin Zentiva 0.5 mg/ 0.4 mg, Kapseln
Kapseln
7
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
dutasteridum
0.5 MG Substance Wirkstoff (Principe actif)
tamsulosini hydrochloridum
0.4 MG Substance WIZUS
tamsulosinum
0.367 MG Substance Wirkstoff (Principe actif)
propylenglycoli dicaprylocapras
299.46 MG Substance HBESI
propylenglycolum
112.8 MG Substance HBESI
E 321
- Substance ANTOX
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
glycerolum
- Substance HNIDK
triglycerida media
- Substance HNIDK
lecithinum ex soja
- Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
0.09 MG Substance HBESI
dibutylis sebacas
- Substance HNIDK
silica colloidalis hydrica
- Substance HNIDK
calcii stearas
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
gelatina
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammoniae solutio concentrata
- Substance HNIDK
kalii hydroxidum
- Substance HNIDK

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
67959
Drug name
Dutasterid Tamsulosin Zentiva, Kapseln
Galenic form
KAHA
ATC Code
G04CA52
Authorization status
Revoked/Withdrawn
Dispensation category
B
First authorization
12/10/2020
Authorization expiration date
18/03/2026
IT number
05.99.0.
Domain
Human medicine
Field of application
Benigne Prostatahyperplasie

Packaging details

Description (FR)
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce
Description (DE)
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg Ds 7 Stk
Market launch
12/10/2020
Market withdrawal
18/03/2026
Narcotic (BTM)
No

Available generics

Dutasterid Duo Spirig HC, Hartkapseln
CHF 13.25
View
Dutasterid Duo Spirig HC, Hartkapseln
CHF 33.60
View
Dutasterid Duo Spirig HC, Hartkapseln
CHF 67.85
View
Dutasterid-Tamsulosin-Mepha, Kapseln
CHF 13.25
View
Dutasterid-Tamsulosin-Mepha, Kapseln
CHF 33.60
View
Dutasterid-Tamsulosin-Mepha, Kapseln
CHF 67.85
View
Dutasterid Tamsulosin Sandoz eco, Kapseln
CHF 14.35
View
Dutasterid Tamsulosin Sandoz eco, Kapseln
CHF 33.60
View
Dutasterid Tamsulosin Sandoz eco, Kapseln
CHF 67.85
View
Dutasterid-Tamsulosin Xiromed, Hartkapseln
CHF 12.00
View

Other packaging sizes

DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 30 pce
30 KAP
View
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 90 pce
90 KAP
View
Buy us a coffee Explore the data